Exact Mass: 769.6067508

Exact Mass Matches: 769.6067508

Found 500 metabolites which its exact mass value is equals to given mass value 769.6067508, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(O-16:0/20:3(8Z,11Z,14Z))

(2-{[(2R)-3-(hexadecyloxy)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C44H84NO7P (769.5985083999999)


PC(O-16:0/20:3(8Z,11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of palmityl alcohol at the C-1 position and one chain of dihomo-gamma-linolenic acid at the C-2 position. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signalling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodelling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also be synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(O-16:0/20:3(8Z,11Z,14Z)) is found in crustaceans and has been isolated from the Japanese oyster Crassostrea gigas.

   

PC(18:1(11Z)/P-18:1(11Z))

trimethyl[2-({3-[(11Z)-octadec-11-enoyloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato}oxy)ethyl]azanium

C44H84NO7P (769.5985083999999)


PC(18:1(11Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/P-18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(18:1(11Z)/P-18:1(9Z))

trimethyl[2-({3-[(11Z)-octadec-11-enoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]azanium

C44H84NO7P (769.5985083999999)


PC(18:1(11Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(18:1(11Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(9Z)/P-18:1(11Z))

trimethyl[2-({3-[(9Z)-octadec-9-enoyloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato}oxy)ethyl]azanium

C44H84NO7P (769.5985083999999)


PC(18:1(9Z)/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/P-18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(18:1(9Z)/P-18:1(9Z))

trimethyl[2-({3-[(9Z)-octadec-9-enoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]azanium

C44H84NO7P (769.5985083999999)


PC(18:1(9Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/P-18:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(18:1(9Z)/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/P-18:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:2(9Z,12Z)/P-18:0)

trimethyl[2-({2-[(1Z)-octadec-1-en-1-yloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato}oxy)ethyl]azanium

C44H84NO7P (769.5985083999999)


PC(18:2(9Z,12Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/P-18:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The linoleic acid moiety is derived from seed oils, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(20:2(11Z,14Z)/P-16:0)

[2-({2-[(1Z)-hexadec-1-en-1-yloxy]-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl phosphonato}oxy)ethyl]trimethylazanium

C44H84NO7P (769.5985083999999)


PC(20:2(11Z,14Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/P-16:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(20:2(11Z,14Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/P-16:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-16:0/20:2(11Z,14Z))

(2-{[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C44H84NO7P (769.5985083999999)


PC(P-16:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:0/18:2(9Z,12Z))

trimethyl(2-{[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(P-18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:2(9Z,12Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of linoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:2(9Z,12Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of linoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(11Z)/18:1(11Z))

trimethyl(2-{[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(P-18:1(11Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(11Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(11Z)/18:1(9Z))

trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(P-18:1(11Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PC(P-18:1(9Z)/18:1(11Z))

trimethyl(2-{[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(P-18:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(9Z)/18:1(9Z))

trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(P-18:1(9Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(O-18:1(11Z)/18:2(9Z,12Z))

trimethyl(2-{[(2R)-3-[(11Z)-octadec-11-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(O-18:1(11Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(11Z)/18:2(9Z,12Z)), in particular, consists of one chain of Vaccenyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Vaccenyl alcohol moiety is derived from beef fat, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(11Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(11Z)/18:2(9Z,12Z)), in particular, consists of one chain of Vaccenyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Vaccenyl alcohol moiety is derived from beef fat, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(O-18:1(9Z)/18:2(9Z,12Z))

trimethyl(2-{[(2R)-3-[(9Z)-octadec-9-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


PC(O-18:1(9Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(9Z)/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/18:2(9Z,12Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

Peonidin 3-O-arabinoside

trimethyl(2-{[(2R)-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-3-(octadecyloxy)propyl phosphono]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


   

Phenylalanine-betaxanthin

trimethyl(2-{[(2R)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]-3-(octadecyloxy)propyl phosphono]oxy}ethyl)azanium

C44H84NO7P (769.5985083999999)


   

Asteriacerebroside B

Asteriacerebroside B

C44H83NO9 (769.6067508)


   
   
   

Phosphatidylcholine alkenyl 18:1-18:1

Phosphatidylcholine alkenyl 18:1-18:1

C44H84NO7P (769.5985083999999)


   

(2S,3R,4E,8E,2R)-1-O-(beta-D-glucopyranosyl)-N-(2-hydroxyicosanoyl)-4,8-sphingadienine|1-O-beta-D-glucopyranosyl-(2S,3R,4E,8E)-2-[(2R)-hydroxyicosanoylamino]-4,8-octadecadiene-1,3-diol

(2S,3R,4E,8E,2R)-1-O-(beta-D-glucopyranosyl)-N-(2-hydroxyicosanoyl)-4,8-sphingadienine|1-O-beta-D-glucopyranosyl-(2S,3R,4E,8E)-2-[(2R)-hydroxyicosanoylamino]-4,8-octadecadiene-1,3-diol

C44H83NO9 (769.6067508)


   

Asteriacerebroside C

Asteriacerebroside C

C44H83NO9 (769.6067508)


   
   

1-O-(beta-D-glucopyranosyloxy)-(2S,3R,4E,13Z)-2-[(2R)-2-hydroxynonadecanoylamino]-nonadeca-4,13-dien-3-ol

1-O-(beta-D-glucopyranosyloxy)-(2S,3R,4E,13Z)-2-[(2R)-2-hydroxynonadecanoylamino]-nonadeca-4,13-dien-3-ol

C44H83NO9 (769.6067508)


   

GlcCer(d14:1(4E)/24:1(15Z)(2OH))

N-(2-hydroxy-15Z-tetracosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine

C44H83NO9 (769.6067508)


   

GlcCer(d14:2(4E,6E)/24:0(2OH))

N-(2-hydroxy-tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine

C44H83NO9 (769.6067508)


   

GlcCer(d16:2(4E,6E)/22:0(2OH))

N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-4E,6E-hexadecasphingadienine

C44H83NO9 (769.6067508)


   

PC(O-16:0/20:3)

3,5,8-Trioxa-4-phosphaoctacosa-16,19,22-trien-1-aminium, 7-[(hexadecyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, [R-(Z,Z,Z)]-

C44H84NO7P (769.5985083999999)


   

Dihomo-γ-Linolenoyl PAF C-16

1-O-hexadecyl-2-O-(8Z,11Z,14Z-eicosatrienoyl)-sn-glyceryl-3-phosphorylcholine

C44H84NO7P (769.5985083999999)


   

Lecithin

1-(1-Enyl-palmitoyl)-2-eicosadienoyl-sn-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


   

PC(O-18:0/18:3(6Z,9Z,12Z))

1-octadecyl-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


   

PC(O-18:0/18:3(9Z,12Z,15Z))

1-octadecyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


   

1-O-Hexadecyl-2-O-dihomogammalinolenoylglycero-3-phosphocholine

(2-{[3-(hexadecyloxy)-2-[(8E,11E,14E)-icosa-8,11,14-trienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C44H84NO7P (769.5985083999999)


   

PC O-36:3

1-(1Z,11Z-octadecadienyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


   

HexCer 38:2;O3

N-(2-hydroxy-tetracosanoyl)-1-beta-glucosyl-4E,6E-tetradecasphingadienine

C44H83NO9 (769.6067508)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoylamino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoylamino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine

1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine

C44H83NO9 (769.6067508)


A glycophytoceramide having an alpha-D-galactopyranosyl residue at the O-1 position and an icosa-11,14-dienoyl group attached to the nitrogen.

   

1-O-(alpha-D-glucopyranosyl)-N-icosa-11,14-dienoylphytosphingosine

1-O-(alpha-D-glucopyranosyl)-N-icosa-11,14-dienoylphytosphingosine

C44H83NO9 (769.6067508)


A glycophytoceramide having an alpha-D-glucopyranosyl residue at the O-1 position and an icosa-11,14-dienoyl group attached to the nitrogen.

   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

C44H84NO7P (769.5985083999999)


   

HexCer 22:0;2O/16:2;O

HexCer 22:0;2O/16:2;O

C44H83NO9 (769.6067508)


   

HexCer 20:2;2O/18:0;O

HexCer 20:2;2O/18:0;O

C44H83NO9 (769.6067508)


   

HexCer 16:1;2O/22:1;O

HexCer 16:1;2O/22:1;O

C44H83NO9 (769.6067508)


   

HexCer 20:0;2O/18:2;O

HexCer 20:0;2O/18:2;O

C44H83NO9 (769.6067508)


   

HexCer 18:2;2O/20:0;O

HexCer 18:2;2O/20:0;O

C44H83NO9 (769.6067508)


   

[2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

HexCer 18:1;2O/20:1;O

HexCer 18:1;2O/20:1;O

C44H83NO9 (769.6067508)


   

HexCer 21:2;2O/17:0;O

HexCer 21:2;2O/17:0;O

C44H83NO9 (769.6067508)


   

HexCer 22:2;2O/16:0;O

HexCer 22:2;2O/16:0;O

C44H83NO9 (769.6067508)


   

HexCer 21:1;2O/17:1;O

HexCer 21:1;2O/17:1;O

C44H83NO9 (769.6067508)


   

HexCer 17:1;2O/21:1;O

HexCer 17:1;2O/21:1;O

C44H83NO9 (769.6067508)


   

HexCer 22:1;2O/16:1;O

HexCer 22:1;2O/16:1;O

C44H83NO9 (769.6067508)


   

HexCer 20:1;2O/18:1;O

HexCer 20:1;2O/18:1;O

C44H83NO9 (769.6067508)


   

HexCer 19:1;2O/19:1;O

HexCer 19:1;2O/19:1;O

C44H83NO9 (769.6067508)


   

HexCer 18:0;2O/20:2;O

HexCer 18:0;2O/20:2;O

C44H83NO9 (769.6067508)


   

HexCer 16:2;2O/22:0;O

HexCer 16:2;2O/22:0;O

C44H83NO9 (769.6067508)


   

HexCer 19:2;2O/19:0;O

HexCer 19:2;2O/19:0;O

C44H83NO9 (769.6067508)


   

HexCer 17:2;2O/21:0;O

HexCer 17:2;2O/21:0;O

C44H83NO9 (769.6067508)


   

HexCer 16:0;2O/22:2;O

HexCer 16:0;2O/22:2;O

C44H83NO9 (769.6067508)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

C52H83NO3 (769.6372607999999)


   

(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide

(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide

C52H83NO3 (769.6372607999999)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

C52H83NO3 (769.6372607999999)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide

C52H83NO3 (769.6372607999999)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

C52H83NO3 (769.6372607999999)


   

(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetratetraconta-14,17,20,23,26,29,32,35,38,41-decaenamide

(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetratetraconta-14,17,20,23,26,29,32,35,38,41-decaenamide

C52H83NO3 (769.6372607999999)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C52H83NO3 (769.6372607999999)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-(1,3-dihydroxyoctan-2-yl)tetratetraconta-11,14,17,20,23,26,29,32,35,38,41-undecaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-(1,3-dihydroxyoctan-2-yl)tetratetraconta-11,14,17,20,23,26,29,32,35,38,41-undecaenamide

C52H83NO3 (769.6372607999999)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C52H83NO3 (769.6372607999999)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

C52H83NO3 (769.6372607999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

C52H83NO3 (769.6372607999999)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C52H83NO3 (769.6372607999999)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenamide

C52H83NO3 (769.6372607999999)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxydodecan-2-yl)tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxydodecan-2-yl)tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

C52H83NO3 (769.6372607999999)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

C52H83NO3 (769.6372607999999)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxydecan-2-yl)dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxydecan-2-yl)dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

C52H83NO3 (769.6372607999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C52H83NO3 (769.6372607999999)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

C52H83NO3 (769.6372607999999)


   

HexCer 22:3;3O/15:0;(2OH)

HexCer 22:3;3O/15:0;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 23:3;3O/14:0;(2OH)

HexCer 23:3;3O/14:0;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 20:3;3O/17:0;(2OH)

HexCer 20:3;3O/17:0;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 19:3;3O/18:0;(2OH)

HexCer 19:3;3O/18:0;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 13:1;3O/24:2;(2OH)

HexCer 13:1;3O/24:2;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 25:3;3O/12:0;(2OH)

HexCer 25:3;3O/12:0;(2OH)

C43H79NO10 (769.5703674)


   

HexCer 21:3;3O/16:0;(2OH)

HexCer 21:3;3O/16:0;(2OH)

C43H79NO10 (769.5703674)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tetracosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)hexacosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)henicosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]henicos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]icos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]nonadec-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]tricos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]pentacos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]docos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyicosanoylamino)pentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyicosanoylamino)pentacosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]hexacos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxydocosanoylamino)tricosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxydocosanoylamino)tricosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]tricosane-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tetracos-4-ene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]nonadecane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]nonadecane-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)icosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]pentacosane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]pentacosane-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]henicosane-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxytricosanoylamino)docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxytricosanoylamino)docosa-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)nonadeca-4,8-diene-1-sulfonic acid

C45H87NO6S (769.6253761999999)


   

[3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] undecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] undecanoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] (Z)-tridec-9-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] tricosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] tricosanoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (Z)-docos-13-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (Z)-icos-11-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] tridecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] tridecanoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (Z)-heptadec-9-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] pentadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] pentadecanoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-pentadec-9-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-nonadec-9-enoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C44H84NO7P (769.5985083999999)


   

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-dodecanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-dodecanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-decoxy-2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decoxy-2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-dodecoxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecoxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-decanoyloxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-decanoyloxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

2-[4-[3-[(Z)-docos-13-enoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(Z)-docos-13-enoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C48H83NO6 (769.6220057999999)


   
   
   

4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-hexadecoxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hexadecoxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-octadecanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-octadecanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] heptadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] heptadecanoate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] henicosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] henicosanoate

C44H84NO7P (769.5985083999999)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-hexadecanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-hexadecanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C44H84NO7P (769.5985083999999)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[3-[(Z)-hexadec-9-enoxy]-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-hexadec-9-enoxy]-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] nonadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] nonadecanoate

C44H84NO7P (769.5985083999999)


   

[(E,2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxynonadec-4-enyl] dihydrogen phosphate

[(E,2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxynonadec-4-enyl] dihydrogen phosphate

C45H88NO6P (769.6348917999999)


   

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[3-[(E)-tetradec-9-enoyl]oxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-tetradec-9-enoyl]oxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-2-[(2E,4E)-octadeca-2,4-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(2E,4E)-octadeca-2,4-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]pentadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]pentadeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-dodecanoyloxy-2-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-dodecanoyloxy-2-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]henicos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]henicos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[[(2S,3R,4E,8E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(E)-nonadec-9-enoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-nonadec-9-enoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(E)-tetradec-9-enoyl]oxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-tetradec-9-enoyl]oxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-2-[(9E,12E)-octadeca-9,12-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(9E,12E)-octadeca-9,12-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-2-[(9E,11E)-octadeca-9,11-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(9E,11E)-octadeca-9,11-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[3-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(E)-nonadec-9-enoyl]oxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-nonadec-9-enoyl]oxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[[(2S,3R,4E,8E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-heptadecanoyloxy-3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-heptadecanoyloxy-3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

[(2R)-2-[(6E,9E)-octadeca-6,9-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(6E,9E)-octadeca-6,9-dienoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H84NO7P (769.5985083999999)


   

4-[2-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-dodecanoyloxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-dodecanoyloxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-tetradecanoyloxy-2-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-tetradecanoyloxy-2-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[2-tetradecanoyloxy-3-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-tetradecanoyloxy-3-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-heptadecanoyloxy-2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-heptadecanoyloxy-2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

4-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H79NO7 (769.5856223999999)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyheptacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyheptacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tricosanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tricosanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetracosanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetracosanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(henicosanoylamino)-3-hydroxyoctadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(henicosanoylamino)-3-hydroxyoctadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(docosanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(docosanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)hexacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)hexacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentacosanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentacosanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentacos-11-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentacos-11-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxytricosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxytricosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyheptacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyheptacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-3,4-dihydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-3,4-dihydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytricosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytricosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxytritriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxytritriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)octacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)octacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(8E,12E,16E)-3,4-dihydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E,16E)-3,4-dihydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxydotriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxydotriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(decanoylamino)-3-hydroxynonacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(decanoylamino)-3-hydroxynonacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(8E,12E)-3,4-dihydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E)-3,4-dihydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytricosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]henicosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyheptatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyheptatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(19Z,22Z)-triaconta-19,22-dienoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(19Z,22Z)-triaconta-19,22-dienoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tetratriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tetratriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]henicosoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]henicosoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[3,4-dihydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3,4-dihydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H82N2O7P+ (769.5859332)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)hexatriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)hexatriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)hentriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)hentriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)triaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)triaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxypentatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxypentatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

C44H86N2O6P+ (769.6223166)


   

1-hexadecyl-2-[(8Z,11Z,14Z)-eicosatrienoyl]-sn-glycero-3-phosphocholine

1-hexadecyl-2-[(8Z,11Z,14Z)-eicosatrienoyl]-sn-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


A phosphatidylcholine O-36:3 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

phosphatidylcholine O-36:3

phosphatidylcholine O-36:3

C44H84NO7P (769.5985083999999)


A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 3 double bonds.

   

1-(1Z-octadecenyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

1-(1Z-octadecenyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C44H84NO7P (769.5985083999999)


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and linoleoyl (9Z,12Z-octadecadienoyl) respectively.

   

MePC(35:3)

MePC(18:3(1)_17:0)

C44H84NO7P (769.5985083999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(38:2)

Hex1Cer(t20:1_18:1)

C44H83NO9 (769.6067508)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GalCer 14:1;O2/24:1;O

GalCer 14:1;O2/24:1;O

C44H83NO9 (769.6067508)


   

GalCer 14:2;O2/24:0;O

GalCer 14:2;O2/24:0;O

C44H83NO9 (769.6067508)


   

GalCer 15:2;O2/23:0;O

GalCer 15:2;O2/23:0;O

C44H83NO9 (769.6067508)


   

GalCer 16:0;O3/22:2

GalCer 16:0;O3/22:2

C44H83NO9 (769.6067508)


   

GalCer 16:1;O2/22:1;O

GalCer 16:1;O2/22:1;O

C44H83NO9 (769.6067508)


   

GalCer 16:2;O2/22:0;O

GalCer 16:2;O2/22:0;O

C44H83NO9 (769.6067508)


   

GalCer 17:2;O2/21:0;O

GalCer 17:2;O2/21:0;O

C44H83NO9 (769.6067508)


   

GalCer 18:0;O3/20:2

GalCer 18:0;O3/20:2

C44H83NO9 (769.6067508)


   

GalCer 18:1;O2/20:1;O

GalCer 18:1;O2/20:1;O

C44H83NO9 (769.6067508)


   

GalCer 18:2;O2/20:0;O

GalCer 18:2;O2/20:0;O

C44H83NO9 (769.6067508)


   

GalCer 19:2;O2/19:0;O

GalCer 19:2;O2/19:0;O

C44H83NO9 (769.6067508)


   

GalCer 20:0;O3/18:2

GalCer 20:0;O3/18:2

C44H83NO9 (769.6067508)


   

GalCer 20:1;O2/18:1;O

GalCer 20:1;O2/18:1;O

C44H83NO9 (769.6067508)


   

GalCer 20:2;O2/18:0;O

GalCer 20:2;O2/18:0;O

C44H83NO9 (769.6067508)


   

GalCer 21:0;O3/17:2

GalCer 21:0;O3/17:2

C44H83NO9 (769.6067508)


   

GalCer 21:2;O2/17:0;O

GalCer 21:2;O2/17:0;O

C44H83NO9 (769.6067508)


   

GalCer 22:2;O2/16:0;O

GalCer 22:2;O2/16:0;O

C44H83NO9 (769.6067508)


   
   
   

GlcCer 14:1;O2/24:1;O

GlcCer 14:1;O2/24:1;O

C44H83NO9 (769.6067508)


   

GlcCer 14:1;O2(4E)/24:1;O

GlcCer 14:1;O2(4E)/24:1;O

C44H83NO9 (769.6067508)


   

GlcCer 14:2;O2/24:0;O

GlcCer 14:2;O2/24:0;O

C44H83NO9 (769.6067508)


   

GlcCer 14:2;O2(4E,6E)/24:0;O

GlcCer 14:2;O2(4E,6E)/24:0;O

C44H83NO9 (769.6067508)


   

GlcCer 15:2;O2/23:0;O

GlcCer 15:2;O2/23:0;O

C44H83NO9 (769.6067508)


   

GlcCer 16:0;O3/22:2

GlcCer 16:0;O3/22:2

C44H83NO9 (769.6067508)


   

GlcCer 16:1;O2/22:1;O

GlcCer 16:1;O2/22:1;O

C44H83NO9 (769.6067508)


   

GlcCer 16:2;O2/22:0;O

GlcCer 16:2;O2/22:0;O

C44H83NO9 (769.6067508)


   

GlcCer 16:2;O2(4E,6E)/22:0;O

GlcCer 16:2;O2(4E,6E)/22:0;O

C44H83NO9 (769.6067508)


   

GlcCer 17:2;O2/21:0;O

GlcCer 17:2;O2/21:0;O

C44H83NO9 (769.6067508)


   

GlcCer 18:0;O3/20:2

GlcCer 18:0;O3/20:2

C44H83NO9 (769.6067508)


   

GlcCer 18:1;O2/20:1;O

GlcCer 18:1;O2/20:1;O

C44H83NO9 (769.6067508)


   

GlcCer 18:2;O2/20:0;O

GlcCer 18:2;O2/20:0;O

C44H83NO9 (769.6067508)


   

GlcCer 19:2;O2/19:0;O

GlcCer 19:2;O2/19:0;O

C44H83NO9 (769.6067508)


   

GlcCer 20:0;O3/18:2

GlcCer 20:0;O3/18:2

C44H83NO9 (769.6067508)


   

GlcCer 20:1;O2/18:1;O

GlcCer 20:1;O2/18:1;O

C44H83NO9 (769.6067508)


   

GlcCer 20:2;O2/18:0;O

GlcCer 20:2;O2/18:0;O

C44H83NO9 (769.6067508)


   

GlcCer 21:0;O3/17:2

GlcCer 21:0;O3/17:2

C44H83NO9 (769.6067508)


   

GlcCer 21:2;O2/17:0;O

GlcCer 21:2;O2/17:0;O

C44H83NO9 (769.6067508)


   

GlcCer 22:2;O2/16:0;O

GlcCer 22:2;O2/16:0;O

C44H83NO9 (769.6067508)


   
   
   

HexCer 14:1;O2/24:1;2OH

HexCer 14:1;O2/24:1;2OH

C44H83NO9 (769.6067508)


   

HexCer 14:1;O2/24:1;3OH

HexCer 14:1;O2/24:1;3OH

C44H83NO9 (769.6067508)


   

HexCer 14:1;O2/24:1;O

HexCer 14:1;O2/24:1;O

C44H83NO9 (769.6067508)


   

HexCer 14:2;O2/24:0;2OH

HexCer 14:2;O2/24:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 14:2;O2/24:0;3OH

HexCer 14:2;O2/24:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 14:2;O2/24:0;O

HexCer 14:2;O2/24:0;O

C44H83NO9 (769.6067508)


   

HexCer 15:2;O2/23:0;2OH

HexCer 15:2;O2/23:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 15:2;O2/23:0;3OH

HexCer 15:2;O2/23:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 15:2;O2/23:0;O

HexCer 15:2;O2/23:0;O

C44H83NO9 (769.6067508)


   

HexCer 16:0;O3/22:2

HexCer 16:0;O3/22:2

C44H83NO9 (769.6067508)


   

HexCer 16:1;O2/22:1;2OH

HexCer 16:1;O2/22:1;2OH

C44H83NO9 (769.6067508)


   

HexCer 16:1;O2/22:1;3OH

HexCer 16:1;O2/22:1;3OH

C44H83NO9 (769.6067508)


   

HexCer 16:1;O2/22:1;O

HexCer 16:1;O2/22:1;O

C44H83NO9 (769.6067508)


   

HexCer 16:2;O2/22:0;2OH

HexCer 16:2;O2/22:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 16:2;O2/22:0;3OH

HexCer 16:2;O2/22:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 16:2;O2/22:0;O

HexCer 16:2;O2/22:0;O

C44H83NO9 (769.6067508)


   

HexCer 17:2;O2/21:0;2OH

HexCer 17:2;O2/21:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 17:2;O2/21:0;3OH

HexCer 17:2;O2/21:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 17:2;O2/21:0;O

HexCer 17:2;O2/21:0;O

C44H83NO9 (769.6067508)


   

HexCer 18:0;O3/20:2

HexCer 18:0;O3/20:2

C44H83NO9 (769.6067508)


   

HexCer 18:1;O2/20:1;2OH

HexCer 18:1;O2/20:1;2OH

C44H83NO9 (769.6067508)


   

HexCer 18:1;O2/20:1;3OH

HexCer 18:1;O2/20:1;3OH

C44H83NO9 (769.6067508)


   

HexCer 18:1;O2/20:1;O

HexCer 18:1;O2/20:1;O

C44H83NO9 (769.6067508)


   

HexCer 18:2;O2/20:0;2OH

HexCer 18:2;O2/20:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 18:2;O2/20:0;3OH

HexCer 18:2;O2/20:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 18:2;O2/20:0;O

HexCer 18:2;O2/20:0;O

C44H83NO9 (769.6067508)


   

HexCer 19:2;O2/19:0;2OH

HexCer 19:2;O2/19:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 19:2;O2/19:0;3OH

HexCer 19:2;O2/19:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 19:2;O2/19:0;O

HexCer 19:2;O2/19:0;O

C44H83NO9 (769.6067508)


   

HexCer 20:0;O3/18:2

HexCer 20:0;O3/18:2

C44H83NO9 (769.6067508)


   

HexCer 20:1;O2/18:1;2OH

HexCer 20:1;O2/18:1;2OH

C44H83NO9 (769.6067508)


   

HexCer 20:1;O2/18:1;3OH

HexCer 20:1;O2/18:1;3OH

C44H83NO9 (769.6067508)


   

HexCer 20:1;O2/18:1;O

HexCer 20:1;O2/18:1;O

C44H83NO9 (769.6067508)


   

HexCer 20:2;O2/18:0;2OH

HexCer 20:2;O2/18:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 20:2;O2/18:0;3OH

HexCer 20:2;O2/18:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 20:2;O2/18:0;O

HexCer 20:2;O2/18:0;O

C44H83NO9 (769.6067508)


   

HexCer 21:0;O3/17:2

HexCer 21:0;O3/17:2

C44H83NO9 (769.6067508)


   

HexCer 21:2;O2/17:0;2OH

HexCer 21:2;O2/17:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 21:2;O2/17:0;3OH

HexCer 21:2;O2/17:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 21:2;O2/17:0;O

HexCer 21:2;O2/17:0;O

C44H83NO9 (769.6067508)


   

HexCer 22:2;O2/16:0;2OH

HexCer 22:2;O2/16:0;2OH

C44H83NO9 (769.6067508)


   

HexCer 22:2;O2/16:0;3OH

HexCer 22:2;O2/16:0;3OH

C44H83NO9 (769.6067508)


   

HexCer 22:2;O2/16:0;O

HexCer 22:2;O2/16:0;O

C44H83NO9 (769.6067508)


   
   
   

2-hydroxy-n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl)hexadecanimidic acid

2-hydroxy-n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl)hexadecanimidic acid

C44H83NO9 (769.6067508)


   

(2r)-2-hydroxy-n-[(2s,3r,4e,13z)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl]hexadecanimidic acid

(2r)-2-hydroxy-n-[(2s,3r,4e,13z)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl]hexadecanimidic acid

C44H83NO9 (769.6067508)


   

(2r,13z)-2-hydroxy-n-[(2s,3r,4e)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl]docos-13-enimidic acid

(2r,13z)-2-hydroxy-n-[(2s,3r,4e)-3-hydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadec-4-en-2-yl]docos-13-enimidic acid

C44H83NO9 (769.6067508)